Resistència antimicrobiana

SAFE - Superbug Awareness For Education

January-December 2020
Jordi Vila (ISGlobal) and David Miñana (UB)
EIT Health Campus

The aim of SAFE is to perform a service learning activity in the field of microbiology, particularly on antimicrobial resistance, for the training of Graduate/Master/PhD students who in turn will conduct the training of highschool students supervised by university professors/researchers experts on this area. Trainings will include the isolation of strains and search for antibacterial activity from natural sources (e.g. soil).

Students will also participate in activities organized during Science Festivals and World Antibiotic Awareness Week for the diffusion of the AMR issue towards citizens as well as gamification through Micro-Combat (designed by ISGlobal).

Additionally, one of these activities will be a competition among high school students participating in SAFE. The winners will have the opportunity to do a short internship at Roche Diagnostics enriching their vision through the incorporation of an entrepreneurial perspective in the field of antimicrobial resistance.


181,573 euros


Our Team


  • Jordi Vila
    Jordi Vila Research Professor, Director de la Iniciativa de Resistències Antimicrobianes i del programa d'Infeccions Víriques i Bacterianes

ISGlobal team

  • Clara Ballesté
    Clara Ballesté Coordinadora de la Iniciativa de Resistències Antimicrobianes i Assistent de Projectes de Jordi Vila
  • Marina Tarrús
    Marina Tarrús Tècnica de divulgació científica

Altres projectes

Veure projectes passats


Combatent la Resistència Bacteriana a Europa


Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique


Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique


Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.


Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo